<DOC>
	<DOC>NCT03090490</DOC>
	<brief_summary>This open-label, non-randomized, prospective study will evaluate the risk of symptoms recurrence during the ten years after antipsychotic discontinuation in a sample of functionally recovered first-episode patients with schizophrenia spectrum disorder.</brief_summary>
	<brief_title>10-year Follow-up of Clinical Outcome After Antipsychotic Treatment Discontinuation in Psychosis Individuals</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Mental Disorders</mesh_term>
	<mesh_term>Schizophrenia Spectrum and Other Psychotic Disorders</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<criteria>Individuals included in the First Episode Psychosis Clinical Program (PAFIP) at the University Hospital Marqu√©s de Valdecilla (Santander, Spain). A minimum of 18 months on antipsychotic treatment. Meeting clinical remission criteria for at least the 12 months prior to inclusion. Meeting the functional recovery criteria for at least the 6 months prior to inclusion. Stabilized at the lowest effective doses for at least the 3 months prior to inclusion. Meeting Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSMIV) criteria for drug dependence. Meeting DSMIV criteria for mental retardation. Having a history of neurological disease or head injury.</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Treatment</keyword>
	<keyword>Maintenance</keyword>
</DOC>